Position paper: The time for cooperative group study of ropeginterferon alfa-2b in young patients with myeloproliferative neoplasms is now.
Nicole KucineJewell A JessupTodd M CooperRay W UrbanskiE Anders KolbLinda M S ResarPublished in: Pediatric blood & cancer (2023)
Keyphrases